✕
Saturday, June 6, 2026
Breaking
New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·
Tag

frailty

Senolytic Drugs Clear ‘Zombie Cells’ and Extend Healthspan in First Human Aging TrialResearch

Senolytic Drugs Clear ‘Zombie Cells’ and Extend Healthspan in First Human Aging Trial

Dr. Marcus ObiMar 6, 2026 · 2 min read